Cingulate Gears Up for NDA Filing as It Advances ADHD Medication Development
Sep 4, 2024
Cingulate Stock Market Invest
Cingulate Secures $1.86 Million Through Warrant Exercise
Jun 28, 2024
Cingulate Inc. Shares Surge on Positive FDA Guidance for ADHD Drug Candidate
Dec 29, 2023